Ontology highlight
ABSTRACT: Background
The prevalence and mortality risk of depression in people with human immunodeficiency virus (HIV) infection receiving antiretroviral therapy (ART) is higher than in the general population, yet biomarkers for therapeutic targeting are unknown. In the current study, we aimed to identify plasma metabolites associated with depressive symptoms in people with HIV receiving ART.Methods
This is a prospective study of ART-treated HIV-infected adults with or without depressive symptoms assessed using longitudinal Beck Depression Inventory scores. Plasma metabolite profiling was performed in 2 independent cohorts (total n = 99) using liquid and gas chromatography and tandem mass spectrometry.Results
Participants with depressive symptoms had lower neuroactive steroid
SUBMITTER: Mukerji SS
PROVIDER: S-EPMC8136979 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature